Progress on Protein-Based Biocontrol Option for Produce Growers
January 26, 2026 Biotalys and 21st.BIO, a leading Danish precision fermentation technology company, have entered into a strategic partnership to accelerate the production of Biotalys’ protein-based biocontrol solutions. This collaboration will leverage 21st.BIO’s proprietary fermentation platform to support the production of Biotalys’ AGROBODY agricultural biocontrol products at commercially competitive costs.
21st.BIO offers a precision fermentation platform, powered by production strains refined over more than four decades and proven in broad commercial use. Part of 21st.BIO’s advanced precision fermentation technology is licensed from Novonesis, and the new collaboration will integrate 21st.BIO’s capabilities with prior work conducted by Biotalys and Novonesis. This collaboration is expected to expand process development options and support efficient, large-scale manufacturing of Biotalys’ precision biocontrol products.
“This partnership marks an important strategic step in strengthening the technical backbone of our AGROBODY platform,” says Kevin Helash, CEO of Biotalys.
In line with the transition to this new agreement, Biotalys and Novonesis will conclude their collaboration.
For more information, visit biotalys.com.